Novogen (KZIA) Competitors $9.82 -0.14 (-1.41%) Closing price 04:00 PM EasternExtended Trading$9.82 0.00 (0.00%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KZIA vs. LIAN, GRCE, NBRV, XCUR, SCLX, MURA, OSTX, LTRN, MRSN, and MDCXShould you be buying Novogen stock or one of its competitors? The main competitors of Novogen include LianBio (LIAN), Grace Therapeutics (GRCE), Nabriva Therapeutics (NBRV), Exicure (XCUR), Scilex (SCLX), Mural Oncology (MURA), OS Therapies (OSTX), Lantern Pharma (LTRN), Mersana Therapeutics (MRSN), and Medicus Pharma (MDCX). These companies are all part of the "pharmaceutical products" industry. Novogen vs. Its Competitors LianBio Grace Therapeutics Nabriva Therapeutics Exicure Scilex Mural Oncology OS Therapies Lantern Pharma Mersana Therapeutics Medicus Pharma LianBio (NASDAQ:LIAN) and Novogen (NASDAQ:KZIA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation. Do analysts recommend LIAN or KZIA? Novogen has a consensus target price of $14.00, suggesting a potential upside of 42.57%. Given Novogen's stronger consensus rating and higher possible upside, analysts clearly believe Novogen is more favorable than LianBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Novogen 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media favor LIAN or KZIA? In the previous week, Novogen had 1 more articles in the media than LianBio. MarketBeat recorded 1 mentions for Novogen and 0 mentions for LianBio. Novogen's average media sentiment score of 1.87 beat LianBio's score of 0.00 indicating that Novogen is being referred to more favorably in the news media. Company Overall Sentiment LianBio Neutral Novogen Very Positive Do insiders and institutionals have more ownership in LIAN or KZIA? 74.8% of LianBio shares are held by institutional investors. Comparatively, 30.9% of Novogen shares are held by institutional investors. 7.6% of LianBio shares are held by insiders. Comparatively, 1.0% of Novogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings and valuation, LIAN or KZIA? Novogen has higher revenue and earnings than LianBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.06Novogen$1.51M6.57-$17.56MN/AN/A Which has more volatility and risk, LIAN or KZIA? LianBio has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Novogen has a beta of 2.64, indicating that its stock price is 164% more volatile than the S&P 500. Is LIAN or KZIA more profitable? Novogen's return on equity of 0.00% beat LianBio's return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% Novogen N/A N/A N/A SummaryNovogen beats LianBio on 11 of the 13 factors compared between the two stocks. Get Novogen News Delivered to You Automatically Sign up to receive the latest news and ratings for KZIA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KZIA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KZIA vs. The Competition Export to ExcelMetricNovogenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.03M$3.07B$5.70B$9.51BDividend YieldN/A2.36%4.69%4.01%P/E RatioN/A21.0428.0720.05Price / Sales6.57284.46448.5799.42Price / CashN/A42.7636.2258.56Price / Book-0.998.378.665.87Net Income-$17.56M-$55.19M$3.25B$258.55M7 Day Performance-3.25%5.89%4.20%2.23%1 Month Performance49.01%17.63%10.82%12.76%1 Year Performance-52.78%5.09%34.70%19.36% Novogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KZIANovogen4.0194 of 5 stars$9.82-1.4%$14.00+42.6%-44.7%$10.03M$1.51M0.0012Positive NewsLIANLianBioN/A$0.43+3.5%N/A-82.6%$46.09MN/A-0.53110GRCEGrace Therapeutics2.5508 of 5 stars$3.31-3.8%$12.00+262.5%N/A$45.78MN/A-3.72N/APositive NewsHigh Trading VolumeNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070XCURExicure1.3417 of 5 stars$7.03-3.3%N/A+1,945.6%$44.42MN/A-1.8450Gap UpSCLXScilex2.3905 of 5 stars$6.32-2.2%$455.00+7,099.4%-82.1%$43.94M$50.71M-0.2280News CoverageMURAMural Oncology3.4217 of 5 stars$2.54+4.1%$12.00+372.4%-28.3%$43.87MN/A-0.33119OSTXOS Therapies2.0558 of 5 stars$1.56-8.2%$18.00+1,053.8%N/A$43.83MN/A-1.81N/AGap UpLTRNLantern Pharma3.0719 of 5 stars$3.99+8.4%$25.00+526.6%-3.6%$43.01MN/A-2.1720High Trading VolumeMRSNMersana Therapeutics4.0018 of 5 stars$0.34-0.3%$5.20+1,416.0%-84.9%$42.75M$40.50M-0.58150News CoverageStock SplitMDCXMedicus Pharma2.3288 of 5 stars$3.13+3.3%$23.50+650.8%N/A$42.47MN/A-2.70N/AUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies LIAN Alternatives GRCE Alternatives NBRV Alternatives XCUR Alternatives SCLX Alternatives MURA Alternatives OSTX Alternatives LTRN Alternatives MRSN Alternatives MDCX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KZIA) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novogen Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Novogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
